Long COVID, the prolonged illness and fatigue suffered by a small proportion of those
infected with SARS‐CoV‐2, is placing an increasing burden on individuals and society. A …

The novel coronavirus disease 19 (COVID‐19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS‐CoV‐2), can have two phases: acute (generally 4 weeks …

There is strong evidence of brain-related abnormalities in COVID-19,,,,,,,,,,,–. However, it
remains unknown whether the impact of SARS-CoV-2 infection can be detected in milder …

There is strong evidence for brain-related pathologies in COVID-19, some of which could be
a consequence of viral neurotropism, or of neuroinflammation following viral infection. Most …

As severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) infections have
been shown to affect the central nervous system, the investigation of associated alterations …

An altered sense of smell and taste was recognized as one of the most characteristic
symptoms of coronavirus infection disease (COVID-19). Despite most patients experiencing …

Background Neurological symptoms associated with coronavirus disease 2019 (COVID‐19),
such as fatigue and smell/taste changes, persist beyond infection. However, little is known of …

Cohort studies that quantify volumetric brain data among individuals with different levels of
COVID-19 severity are presently limited. It is still uncertain whether there exists a potential …

Introduction Magnetic resonance imaging (MRI) of the brain could be a key diagnostic and
research tool for understanding the neuropsychiatric complications of COVID-19. For …

We examined the histopathological changes in the olfactory mucosa of cynomolgus and
rhesus macaque models of SARS-CoV-2 infection. SARS-CoV-2 infection induced severe …